Logo image
Microalgae as sources of pharmaceuticals and other biologically active compounds
Journal article   Peer reviewed

Microalgae as sources of pharmaceuticals and other biologically active compounds

M.A. Borowitzka
Journal of Applied Phycology, Vol.7(1), pp.3-15
1995
url
Link to Published Version *Subscription may be requiredView

Abstract

In the last decade the screening of microalgae, especially the cyanobacteria (blue-green algae), for antibiotics and pharmacologically active compounds has received ever increasing interest. A large number of antibiotic compounds, many with novel structures, have been isolated and characterised. Similarly many cyanobacteria have been shown to produce antiviral and antineoplastic compounds. A range of pharmacological activities have also been observed with extracts of microalgae, however the active principles are as yet unknown in most cases. Several of the bioactive compounds may find application in human or veterinary medicine or in agriculture. Others should find application as research tools or as structural models for the development of new drugs. The microalgae are particularly attractive as natural sources of bioactive molecules since these algae have the potential to produce these compounds in culture which enables the production of structurally complex molecules which are difficult or impossible to produce by chemical synthesis.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#6 Clean Water and Sanitation

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
3 Agriculture, Environment & Ecology
3.171 Photoproductivity
3.171.477 Microalgae Biotechnology
Web Of Science research areas
Biotechnology & Applied Microbiology
Marine & Freshwater Biology
ESI research areas
Plant & Animal Science
Logo image